Name of
applicant:
|
GlaxoSmithKline
plc
|
|||
Name of
scheme:
|
GlaxoSmithKline
Share Option Plan - Ordinary Shares
|
|||
Period
of return:
|
From:
|
1 May
2017
|
To:
|
31
October 2017
|
Balance
of unallotted securities under scheme(s) from previous
return:
|
4,104,101
|
|||
Plus: The amount by which the block scheme(s) has been
increased since the date of the last return (if any increase has
been applied for):
|
0
|
|||
Less: Number of securities issued/allotted under
scheme(s) during period (see LR3.5.7G):
|
543,609
|
|||
Equals: Balance under scheme(s) not yet
issued/allotted at end of period:
|
3,559,772
|
Name of
contact:
|
Victoria
Whyte
|
Telephone
number of contact:
|
020
8047 5000
|
Name of
applicant:
|
GlaxoSmithKline
plc
|
|||
Name of
scheme:
|
GlaxoSmithKline
Share Option Plan - ADS
|
|||
Period
of return:
|
From:
|
1 May
2017
|
To:
|
31
October 2017
|
Balance
of unallotted securities under scheme(s) from previous
return:
|
8,795,814
|
|||
Plus: The amount by which the block scheme(s) has been
increased since the date of the last return (if any increase has
been applied for):
|
0
|
|||
Less: Number of securities issued/allotted under
scheme(s) during period (see LR3.5.7G):
|
611,414
|
|||
Equals: Balance under scheme(s) not yet
issued/allotted at end of period:
|
8,185,120
|
Name of
contact:
|
Victoria
Whyte
|
Telephone
number of contact:
|
020
8047 5000
|
Name of
applicant:
|
GlaxoSmithKline
plc
|
|||
Name of
scheme:
|
Glaxo
Wellcome UK Share Option Scheme
|
|||
Period
of return:
|
From:
|
1 May
2017
|
To:
|
31
October 2017
|
Balance
of unallotted securities under scheme(s) from previous
return:
|
5,119,750
|
|||
Plus: The amount by which the block scheme(s) has been
increased since the date of the last return (if any increase has
been applied for):
|
0
|
|||
Less: Number of securities issued/allotted under
scheme(s) during period (see LR3.5.7G):
|
0
|
|||
Equals: Balance under scheme(s) not yet
issued/allotted at end of period:
|
5,119,750
|
Name of
contact:
|
Victoria
Whyte
|
Telephone
number of contact:
|
020
8047 5000
|
Name of
applicant:
|
GlaxoSmithKline
plc
|
|||
Name of
scheme:
|
Glaxo
Wellcome International Share Option Scheme
|
|||
Period
of return:
|
From:
|
1 May
2017
|
To:
|
31
October 2017
|
Balance
of unallotted securities under scheme(s) from previous
return:
|
13,267,156
|
|||
Plus: The amount by which the block scheme(s) has been
increased since the date of the last return (if any increase has
been applied for):
|
0
|
|||
Less: Number of securities issued/allotted under
scheme(s) during period (see LR3.5.7G):
|
0
|
|||
Equals: Balance under scheme(s) not yet
issued/allotted at end of period:
|
13,267,156
|
Name of
contact:
|
Victoria
Whyte
|
Telephone
number of contact:
|
020
8047 5000
|
Name of
applicant:
|
GlaxoSmithKline
plc
|
|||
Name of
scheme:
|
Glaxo
Wellcome 1999 Share Option Plan
|
|||
Period
of return:
|
From:
|
1 May
2017
|
To:
|
31
October 2017
|
Balance
of unallotted securities under scheme(s) from previous
return:
|
1,040,000
|
|||
Plus: The amount by which the block scheme(s) has been
increased since the date of the last return (if any increase has
been applied for):
|
0
|
|||
Less: Number of securities issued/allotted under
scheme(s) during period (see LR3.5.7G):
|
0
|
|||
Equals: Balance under scheme(s) not yet
issued/allotted at end of period:
|
1,040,000
|
Name of
contact:
|
Victoria
Whyte
|
Telephone
number of contact:
|
020
8047 5000
|
Name of
applicant:
|
GlaxoSmithKline
plc
|
|||
Name of
scheme:
|
SmithKline
Beecham 1989 Executive Share Option Plan - Approved - Ordinary
Shares
|
|||
Period
of return:
|
From:
|
1 May
2017
|
To:
|
31
October 2017
|
Balance
of unallotted securities under scheme(s) from previous
return:
|
163,606
|
|||
Plus: The amount by which the block scheme(s) has been
increased since the date of the last return (if any increase has
been applied for):
|
0
|
|||
Less: Number of securities issued/allotted under
scheme(s) during period (see LR3.5.7G):
|
0
|
|||
Equals: Balance under scheme(s) not yet
issued/allotted at end of period:
|
163,606
|
Name of
contact:
|
Victoria
Whyte
|
Telephone
number of contact:
|
020
8047 5000
|
Name of
applicant:
|
GlaxoSmithKline
plc
|
|||
Name of
scheme:
|
SmithKline
Beecham 1989 Executive Share Option Plan - Unapproved -
ADS
|
|||
Period
of return:
|
From:
|
1 May
2017
|
To:
|
31
October 2017
|
Balance
of unallotted securities under scheme(s) from previous
return:
|
275,420
|
|||
Plus: The amount by which the block scheme(s) has been
increased since the date of the last return (if any increase has
been applied for):
|
0
|
|||
Less: Number of securities issued/allotted under
scheme(s) during period (see LR3.5.7G):
|
0
|
|||
Equals: Balance under scheme(s) not yet
issued/allotted at end of period:
|
275,420
|
Name of
contact:
|
Victoria
Whyte
|
Telephone
number of contact:
|
020
8047 5000
|
Name of
applicant:
|
GlaxoSmithKline
plc
|
|||
Name of
scheme:
|
SmithKline
Beecham 1989 Executive Share Option Plan - Unapproved -
Ordinary
|
|||
Period
of return:
|
From:
|
1 May
2017
|
To:
|
31
October 2017
|
Balance
of unallotted securities under scheme(s) from previous
return:
|
100,000
|
|||
Plus: The amount by which the block scheme(s) has been
increased since the date of the last return (if any increase has
been applied for):
|
0
|
|||
Less: Number of securities issued/allotted under
scheme(s) during period (see LR3.5.7G):
|
0
|
|||
Equals: Balance under scheme(s) not yet
issued/allotted at end of period:
|
100,000
|
Name of
contact:
|
Victoria
Whyte
|
Telephone
number of contact:
|
020
8047 5000
|
Name of
applicant:
|
GlaxoSmithKline
plc
|
|||
Name of
scheme:
|
GlaxoSmithKline
plc Share Save Plan 2012
|
|||
Period
of return:
|
From:
|
1 May
2017
|
To:
|
31
October 2017
|
Balance
of unallotted securities under scheme(s) from previous
return:
|
1,635,325
|
|||
Plus: The amount by which the block scheme(s) has been
increased since the date of the last return (if any increase has
been applied for):
|
0
|
|||
Less: Number of securities issued/allotted under
scheme(s) during period (see LR3.5.7G):
|
93,255
|
|||
Equals: Balance under scheme(s) not yet
issued/allotted at end of period:
|
1,542,070
|
Name of
contact:
|
Victoria
Whyte
|
Telephone
number of contact:
|
020
8047 5000
|
Name of
applicant:
|
GlaxoSmithKline
plc
|
|||
Name of
scheme:
|
GlaxoSmithKline
plc 2009 Deferred Annual Bonus Plan
|
|||
Period
of return:
|
From:
|
1 May
2017
|
To:
|
31
October 2017
|
Balance
of unallotted securities under scheme(s) from previous
return:
|
200,071
|
|||
Plus: The amount by which the block scheme(s) has been
increased since the date of the last return (if any increase has
been applied for):
|
0
|
|||
Less: Number of securities issued/allotted under
scheme(s) during period (see LR3.5.7G):
|
989
|
|||
Equals: Balance under scheme(s) not yet
issued/allotted at end of period:
|
199,082
|
Name of
contact:
|
Victoria
Whyte
|
Telephone
number of contact:
|
020
8047 5000
|
|
GlaxoSmithKline plc
|
|
(Registrant)
|
|
|
Date: November
09, 2017
|
|
|
|
|
By: VICTORIA
WHYTE
--------------------------
|
|
|
|
Victoria Whyte
|
|
Authorised
Signatory for and on
|
|
behalf
of GlaxoSmithKline plc
|